Vascularity of uterine myomas: Assessment by color and pulsed Doppler ultrasound

International Journal of Gynecology and Obstetrics

Volumn 54, Issue 3, 1996, Pages 245-250

  Sosic A ^a   Skupski, D W ^a   Streltzoff, J ^a   Yun, H ^b   Chervenak, F A ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b JERSEY CITY MEDICAL CENTER   (United States)

Author keywords

Color Doppler; Myomas; Ultrasound

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; TUMOR VOLUME; UTERUS MYOMA; VASCULAR RESISTANCE;

EID: 0030248619     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-7292(96)02722-1     Document Type: Article

References (27)

1. [1] Kurjak A, Zalud I. The characterization of uterine tumors by transvaginal color Doppler. Ultrasound Obstet Gynecol 1991; 1: 50-52.
2. [2] Kurjak A, Kupesic-Urek S, Mine D. The assessment of benign uterine tumor vascularization by transvaginal color Doppler. Ultrasound Med Biol 1992; 18: 645-649.
3. [3] Thompson RS, Trudinger BJ, Cook CM. Doppler ultrasound waveform indices: A/B ratio, pulsatility and Pourcelot ratio. Br J Obstet Gynaecol 1988; 95: 581-588.
4. [4] Scholtes MCW, Wladimiroff JW, van Rijen HJM, Hop WCJ. Uterine and ovarian flow velocity waveforms in the normal menstrual cycle: a transvaginal Doppler study. Fertil Steril 1989; 52: 981-985.
5. [5] Steer CV, Campbell S, Pampiglione JS, Kingland CR, Mason BA, Collins WP. Transvaginal colour flow imaging of the uterine arteries during the ovarian and menstrual cycles. Hum Reprod 1990; 5: 391-395.
6. [6] Jauniaux E, Jurkovic D, Campbell S. In vivo investigations of the anatomy and the physiology of early human placental circulations. Ultrasound Obstet Gynecol 1991; 1: 435-445.
7. [7] Bonilla-Musoles F, Marti MC, Ballester MJ, Raga F, Osborne NG. Normal uterine arterial blood flow in postmenopausal women assessed by transvaginal color Doppler ultrasonography. J Ultrasound Med 1995; 14: 491-494.
8. [8] Bonilla-Musoles F, Marti MC, Ballester MJ, Raga F, Osborne NG. Transvaginal color Doppler assessment of endometrial status in normal postmenopausal women: the effect of hormone replacement therapy. J Ultrasound Med 1995; 14: 497-501.
9. [9] Lantta M, Karkahainen J, Lehtovirta P. Progesterone and estradiol receptors in the cytosol of the human uterine artery. Am J Obstet Gynecol 1983; 147: 627-633.
10. [10] Soules MR, McCarty Jr KS. Leiomyomas: steroid receptor content - variation within normal menstrual cycle. Am J Obstet Gynecol 1982; 143: 6-11.
11. [11] Greiss FC, Anderson SG. Effects of ovarian hormones on the uterine vascular bed. Am J Obstet Gynecol 1970; 107: 829-836.
12. [12] de Zigler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone. Fertil Steril 1991; 55: 775-779.
13. [13] Sladkevicius P, Valentin L, Marsal K. Transvaginal Doppler examination of uteri with myomas. J Clin Ultrasound 1996; 24: 135-140.
14. [14] Carter JR, Lau M, Saltzman AK, Hartenbach EM, Chen MD, Johnson PR, et al. Gray scale and color flow Doppler characterization of uterine tumors. J Ultrasound Med 1994; 13: 835-840.
15. [15] Creighton S, Bourne TH, Lawton FG, Crayford TJB, Vyas S, Campbell S, et al. Use of transvaginal ultrasonography with color Doppler imaging to determine an appropriate treatment regimen for uterine fibroids with a GnRH agonist before surgery: a preliminary study. Ultrasound Obstet Gynecol 1994; 4: 494-498.
16. [16] Matta WHM, Stabile I, Shaw RW, Campbell S. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist buserelin. Fertil Steril 1988; 49: 1083-1085.
17. [17] Friedman AJ. Use of gonadotropin-releasing hormone agonists before myomectomy. Clin Obstet Gynecol 1993; 36: 650-659.
18. [18] Stovall TG, Summit RL, Washburn SA, Ling FW. Gonadotropin-releasing agonist use before hysterectomy. Am J Obstet Gynecol 1994; 170: 1744-1751.
19. [19] Barter JF, Smith EB, Szpak CA, Hinshaw W, Clarke-Parson DL, Creasman WT. Leiomyosarcoma of the uterus: clinicopathologic study of 21 cases. Gynecol Oncol 1985; 21: 220-227.
20. [20] Butram V, Reiter R. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981; 36: 433-445.
21. [21] Schwanz LB, Diamond MP, Schwartz PE. Leiomyosarcoma: clinical presentation. Am J Obstet Gynecol 1993; 168: 180-183.
22. [22] Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994; 83: 414-418.
23. [23] McLeod AJ, Zornoza J, Shirkhoda A. Leiomyosarcoma: computed tomographic findings. Radiology 1984; 152: 133-136.
24. [24] Janus C, White M, Dottino P, Brodman M, Goodman H. Uterine leiomyosarcoma - magnetic resonance imaging. Gynecol Oncol 1989; 32: 79-81.
25. [25] Baltarowich OH, Kurtz AB, Pennell RG, Needleman L, Vilaro MM, Goldberg BB. Pitfalls in the sonographic diagnosis of uterine fibroids. AmJ Roentgenol 1981; 151: 725-728.
26. [26] Seki K, Hoshihara T, Nagata I. Leiomyosarcoma of the uterus: ultrasonography and serum lactate dehydrogenase level. Gynecol Obstet Invest 1992; 33: 114-118.
27. [27] Kurjak A, Kupesic S, Shalan H, Jukic S, Kosuta D, Ilijas M. Uterine sarcoma. A report of 10 cases studied by transvaginal color and pulsed Doppler sonography. Gynecol Oncol 1995; 59: 342-346.